Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes
CONCLUSIONS: Combining BIAsp 30 + GLP-1RA provides glycaemic control with no significant difference to that of propensity score-matched people receiving basal insulin+GLP-1RA, with no increase in hypoglycaemia risk or weight gain.PMID:38088483 | DOI:10.1111/dme.15267 (Source: Molecular Medicine)
Source: Molecular Medicine - December 13, 2023 Category: Molecular Biology Authors: Melanie Davies Amra Ciric Alibegovic Gayathri Anil Uffe Christian Braae Anders Boeck Jensen Rikke Baastrup Nordsborg Source Type: research
Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes
CONCLUSIONS: Combining BIAsp 30 + GLP-1RA provides glycaemic control with no significant difference to that of propensity score-matched people receiving basal insulin+GLP-1RA, with no increase in hypoglycaemia risk or weight gain.PMID:38088483 | DOI:10.1111/dme.15267 (Source: Molecular Medicine)
Source: Molecular Medicine - December 13, 2023 Category: Molecular Biology Authors: Melanie Davies Amra Ciric Alibegovic Gayathri Anil Uffe Christian Braae Anders Boeck Jensen Rikke Baastrup Nordsborg Source Type: research
Comparison of treatment with insulin detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes. A retrospective study
CONCLUSION: The use of insulin detemir was found to be equally effective and safe compared to NPH in women with GDM.PMID:37775682 | DOI:10.1007/s42000-023-00490-2 (Source: Hormones)
Source: Hormones - September 29, 2023 Category: Endocrinology Authors: Paraskevi Kazakou Stavroula A Paschou Marina Mitropoulou Vasiliki Vasileiou Vasiliki Sarantopoulou Eleni Anastasiou Source Type: research
Insulin Detemir Versus Glibenclamide in Gestational Diabetes Mellitus: A Retrospective Cohort Study
CONCLUSIONS: In pregnant women with GDM, glucose control on IDet yielded comparable results as on glibenclamide, except for a significantly lower rate of LGA neonates.PMID:37381932 (Source: The Israel Medical Association Journal)
Source: The Israel Medical Association Journal - June 29, 2023 Category: General Medicine Authors: Dorit Ravid Michal Kovo Sophia Leytes Yael Yagur Maty Fakterman Omer Weitzner Source Type: research
